Scribd Logo
Upload

Welcome to Scribd!

  • Percent Non Iol Antibiotik

    Uploaded by

    ANTONIUS BAYU
    3 views2 pages
    The document summarizes procedures performed and the percentage of each for various antibiotics. The most common procedures included vitrectomy with silicone oil (14.3%), vitrectomy with silicone oil and sulfur hexafluoride (5.3%), cryo ulcus (5.3%), trabeculoplasty (4.5%), and scleral hectic (4.5%). Meropenem was most commonly used for vitrectomy with silicone oil (3.8%), paracentesis pus (3.0%), and vitrectomy with silicone oil (1.5%). Cefazoline was used across a variety of minor procedures each less than 2% of cases.

    Original Description:

    percentase antibiotik

    Original Title

    Percent Non Iol antibiotik

    Copyright

    © © All Rights Reserved

    Available Formats

    XLSX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document summarizes procedures performed and the percentage of each for various antibiotics. The most common procedures included vitrectomy with silicone oil (14.3%), vitrectomy with silicone oil and sulfur hexafluoride (5.3%), cryo ulcus (5.3%), trabeculoplasty (4.5%), and scleral hectic (4.5%). Meropenem was most commonly used for vitrectomy with silicone oil (3.8%), paracentesis pus (3.0%), and vitrectomy with silicone oil (1.5%). Cefazoline was used across a variety of minor procedures each less than 2% of cases.

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    3 views2 pages

    Percent Non Iol Antibiotik

    Uploaded by

    ANTONIUS BAYU
    The document summarizes procedures performed and the percentage of each for various antibiotics. The most common procedures included vitrectomy with silicone oil (14.3%), vitrectomy with silicone oil and sulfur hexafluoride (5.3%), cryo ulcus (5.3%), trabeculoplasty (4.5%), and scleral hectic (4.5%). Meropenem was most commonly used for vitrectomy with silicone oil (3.8%), paracentesis pus (3.0%), and vitrectomy with silicone oil (1.5%). Cefazoline was used across a variety of minor procedures each less than 2% of cases.

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 2

    nama tindakan CountOftindakan

    PERCENT
    CEFAZOLINE INJ DISCISI ASP (GENERAL) 1 0.8%
    ASPIRASI HIPOPION (LOCAL) 2 1.5%
    EVISERASI (GENERAL) 4 3.0%
    CEFOTAXIM INJEKSI
    EVISERASI (LOCAL) 5 3.8%
    HECTING SCLERA (GENERAL) 6 4.5%
    CRYO ULCUS (LOCAL) 7 5.3%
    ECCE/ICCE (GENERAL) 1 0.8%
    ECCE/ICCE (LOCAL) 2 1.5%
    EVAKUASI SILICON (LOCAL) 7 5.3%
    FGX + ENDOLASER + SO BARU (LOCAL) 1 0.8%
    IMPLANT GDD (GENERAL) 1 0.8%
    INJEKSI VANCOMICIN (LOCAL) 2 1.5%
    IRIDECTOMY (OPTIC, PREVENTIF & 1 0.8%
    TERAPATIK) (LOCAL)
    KRATO PLASTY (GENERAL) 2 1.5%
    PARACENTHESA DARAH (LOCAL) 1 0.8%
    Second Scleral Fixation(SF) (LOCAL) 1 0.8%
    CEFTAZIDIME 1 GRAM
    SICS (LOCAL) 1 0.8%
    SICS + PAPILOPLASTY (GENERAL) 1 0.8%
    TRABEC (LOCAL) 6 4.5%
    VIT + EL (GENERAL) 4 3.0%
    VIT + EL (LOCAL) 2 1.5%
    VIT + EL + SF6 (GENERAL) 7 5.3%
    VIT + EL + SIL.OIL (GENERAL) 19 14.3%

    VITREC + EL + DROP NUCLEUS (GENERAL) 2 1.5%

    VITRECTOMY + EL (LOCAL) 4 3.0%

    VITRECTOMY(SB+VIT+EL+SF6) (GENERAL) 4 3.0%

    CEFTRIAXONE INJ 1 GRAM EVAKUASI SILICON (LOCAL) 2 1.5%


    TRABEC (LOCAL) 2 1.5%
    CEFXON 1 GR INJEKSI
    VIT + EL + SF6 (GENERAL) 3 2.3%
    GLYBOTIC 250 MG INJ EVISERASI (GENERAL) 1 0.8%
    TRABEC (LOCAL) 1 0.8%
    VIT + EL (GENERAL) 2 1.5%
    LACEDIM INJEKSI
    VIT + EL + SIL.OIL (GENERAL) 3 2.3%
    VITRECTOMY + EL (LOCAL) 2 1.5%
    ECCE/ICCE (LOCAL) 2 1.5%
    INJEKSI VANCOMICIN (LOCAL) 12 9.0%
    MEROPENEM
    PARACENTHESA PUS (LOCAL) 4 3.0%
    VITRECTOMY + EL (LOCAL) 5 3.8%
    Chart Title
    VITRECTOMY + EL (LOCAL) 3.8%
    5
    MG INJ INJEKSI MEROPENEM

    PARACENTHESA PUS (LOCAL) 3.0%


    4
    INJEKSI VANCOMICIN (LOCAL) 9.0%
    12
    ECCE/ICCE (LOCAL) 1.5%
    2
    VITRECTOMY + EL (LOCAL) 1.5%
    2
    VIT + EL + SIL.OIL (GENERAL) 2.3%
    3
    VIT + EL (GENERAL) 1.5%
    2
    LACEDIM

    TRABEC (LOCAL) 0.8%


    1
    EVISERASI (GENERAL) 0.8%
    1
    250SI
    INJEK
    GRAM

    VIT + EL + SF6 (GENERAL) 2.3%


    3
    TIC
    11GR
    GLYBO

    TRABEC (LOCAL) 1.5%


    2
    EVAKUASI SILICON (LOCAL) 1.5%
    2
    INJ
    CEFXON
    CEFTRIAXONE

    VITRECTOMY(SB+VIT+EL+SF6) (GENERAL) 3.0%


    4
    VITRECTOMY + EL (LOCAL) 3.0%
    4
    VITREC + EL + DROP NUCLEUS (GENERAL) 1.5%
    2
    VIT + EL + SIL.OIL (GENERAL) 14.3%
    19
    VIT + EL + SF6 (GENERAL) 5.3%
    7
    VIT + EL (LOCAL) 1.5%
    2
    VIT + EL (GENERAL) 3.0%
    4
    TRABEC (LOCAL) 4.5%
    6
    SICS + PAPILOPLASTY (GENERAL) 0.8%
    1
    CEFTAZIDIME 1 GRAM

    CEFTAZIDIM SICS (LOCAL) 0.8%


    1
    E Second Scleral Fixation(SF) (LOCAL) 0.8%
    1
    PARACENTHESA DARAH (LOCAL) 0.8%
    1
    KRATO PLASTY (GENERAL) 1.5%
    2
    IRIDECTOMY (OPTIC, PREVENTIF & TERAPATIK) (LOCAL) 0.8%
    1
    INJEKSI VANCOMICIN (LOCAL) 1.5%
    2
    IMPLANT GDD (GENERAL) 0.8%
    1
    FGX + ENDOLASER + SO BARU (LOCAL) 0.8%
    1
    EVAKUASI SILICON (LOCAL) 5.3%
    7
    ECCE/ICCE (LOCAL) 1.5%
    2
    ECCE/ICCE (GENERAL) 0.8%
    1
    CRYO ULCUS (LOCAL) 5.3%
    7
    HECTING SCLERA (GENERAL) 4.5%
    6
    TAXIM INJEKSI

    EVISERASI (LOCAL) 3.8%


    5
    EVISERASI (GENERAL) 3.0%
    4
    INJ

    ASPIRASI HIPOPION (LOCAL) 1.5%


    2
    CEFO
    CEFAZOLINE

    DISCISI ASP (GENERAL) 0.8%


    1
    0 2 4 6 8 10 12 14 16 18 20

    Column C Column D

    You might also like